nach oben

Erschienen in:

01.12.2008 | Update

Update in Addiction Medicine for the Primary Care Clinician

verfasst von: Adam J. Gordon, David A. Fiellin, Peter D. Friedmann, Marc N. Gourevitch, Kevin L. Kraemer, Julia H. Arnsten, Richard Saitz, for the Society of General Internal Medicine’s Substance Abuse Interest Group

Erschienen in: Journal of General Internal Medicine | Ausgabe 12/2008

Einloggen, um Zugang zu erhalten

Excerpt

The United States Preventive Services Task Force recommends that primary care clinicians assume a major role in screening, identification, treatment, and referral to treatment of unhealthy alcohol and other drug (AOD) use—the spectrum from use that risks health consequences to AOD disorders (abuse and dependence)—in generalist settings.1 In the United States, nicotine dependence, alcohol use, and drug use are the first, third, and ninth leading causes, respectively, of preventable deaths.2 Despite the harmful effects of addiction and improved options for office-based treatments and referral, not all primary care clinicians routinely address AOD use in their patients. …

Whitlock EP, Polen MR, Green CA, Orleans T, Klein J. Behavioral counseling interventions in primary care to reduce risky/harmful alcohol use by adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2004;140(7):557–68.PubMed

Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004;291(10):1238–45.PubMedCrossRef

Alcohol, other drugs, and health: current evidence. Available at: http://www.bu.edu/aodhealth/about.html. Accessed June 1, 2008.

Gordon AJ, Sullivan LE, Alford DP, et al. Update in addiction medicine for the generalist. J Gen Intern Med. 2007;22(8):1190–94.PubMedCrossRef

Vinson DC, Kruse RL, Seale JP. Simplifying alcohol assessment: two questions to identify alcohol use disorders. Alcohol Clin Exp Res. 2007;31(8):1392–8.PubMedCrossRef

Kaner EF, Beyer F, Dickinson HO, et al. Effectiveness of brief alcohol interventions in primary care populations. Cochrane Database Syst Rev. 2007;(2):CD004148.

National Institute on Alcohol Abuse and Alcoholism. Helping patients who drink too much: a clinician’s guide (NIH Publication No. 05–3769). Rockville, MD: U.S. Department of Health & Human Services; 2005.

Timko C, DeBenedetti A, Billow R. Intensive referral to 12-Step self-help groups and 6-month substance use disorder outcomes. Addiction. 2006;101(5):678–88.PubMedCrossRef

Friedmann PD, McCullough D, Chin MH, Saitz R. Screening and intervention for alcohol problems. A national survey of primary care physicians and psychiatrists. J Gen Intern Med. 2000;15(2):84–91.PubMedCrossRef

10.

Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: treatment main effects and matching effects on drinking during treatment. J Stud Alcohol. 1998;59(6):631–9.

11.

Project MATCH secondary a priori hypotheses. Project MATCH Research Group. Addiction. 1997;92(12):1671–98.CrossRef

12.

Project MATCH Research Group. Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcohol Clin Exp Res. 1998;22:1300–11.CrossRef

13.

Timko C, DeBenedetti A. A randomized controlled trial of intensive referral to 12-step self-help groups: one-year outcomes. Drug Alcohol Depend. 2007;90(2–3):270–9.PubMedCrossRef

14.

Johnson BA, Rosenthal N, Capece JA, et al. Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA. 2007;298(14):1641–51.PubMedCrossRef

15.

Conigrave KM, Hall WD, Saunders JB. The AUDIT questionnaire: choosing a cut-off score. Alcohol Use Disorder Identification Test. Addiction. 1995;90(10):1349–56.PubMedCrossRef

16.

Allen JP, Litten RZ, Fertig JB, Babor T. A review of research on the Alcohol Use Disorders Identification Test (AUDIT). Alcohol Clin Exp Res. 1997;21(4):613–9.PubMed

17.

Johnson BA, Rosenthal N, Capece JA, et al. Improvement of physical health and quality of life of alcohol-dependent individuals with topiramate treatment: US multisite randomized controlled trial. Arch Intern Med. 2008;168(11):1188–99.PubMedCrossRef

18.

Martell BA, O’Connor PG, Kerns RD, et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med. 2007;146(2):116–27.PubMed

19.

Kirsh KL, Whitcomb LA, Donaghy K, Passik SD. Abuse and addiction issues in medically ill patients with pain: attempts at clarification of terms and empirical study. Clin J Pain. 2002;18(4 Suppl):S52–S60.PubMedCrossRef

20.

Davis WR, Johnson BD. Prescription opioid use, misuse, and diversion among street drug users in New York City. Drug Alcohol Depend. 2008;92(1–3):267–76.PubMedCrossRef

21.

Becker WC, Sullivan LE, Tetrault JM, Desai RA, Fiellin DA. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates. Drug Alcohol Depend. 2008;94(1–3):38–47.PubMedCrossRef

22.

Clausen T, Anchersen K, Waal H. Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study. Drug Alcohol Depend. 2008;94(1–3):151–7.PubMedCrossRef

23.

Hser YI, Hoffman V, Grella CE, Anglin MD. A 33-year follow-up of narcotics addicts. Arch Gen Psychiatry. 2001;58(5):503–8.PubMedCrossRef

24.

Graham NA, Merlo LJ, Goldberger BA, Gold MS. Methadone- and heroin-related deaths in Florida. Am J Drug Alcohol Abuse. 2008;34(3):347–53.PubMedCrossRef

25.

Center for Substance Abuse Treatment. Summary report of the meeting: methadone mortality- a reassessment. Available at: http://www.dpt.samhsa.gov/pdf/Methadone_Report_10%2018%2007_Brief%20w%20attch.pdf. Accessed July 1, 2008.

26.

Alford DP, LaBelle CT, Richardson JM, et al. Treating homeless opioid dependent patients with buprenorphine in an office-based setting. J Gen Intern Med. 2007;22(2):171–6.PubMedCrossRef

27.

Mintzer IL, Eisenberg M, Terra M, et al. Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings. Ann Fam Med. 2007;5(2):146–50.PubMedCrossRef

Titel: Update in Addiction Medicine for the Primary Care Clinician
verfasst von: Adam J. Gordon
David A. Fiellin
Peter D. Friedmann
Marc N. Gourevitch
Kevin L. Kraemer
Julia H. Arnsten
Richard Saitz
for the Society of General Internal Medicine’s Substance Abuse Interest Group
Publikationsdatum: 01.12.2008
Verlag: Springer-Verlag
Erschienen in: Journal of General Internal Medicine / Ausgabe 12/2008
Print ISSN: 0884-8734
Elektronische ISSN: 1525-1497
DOI: https://doi.org/10.1007/s11606-008-0806-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Update in Addiction Medicine for the Primary Care Clinician

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

Antikörper mobilisiert Neutrophile gegen Krebs

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2008

Distinguished Reviewers

Addressing Intimate Partner Violence with Male Patients: A Review and Introduction of Pilot Guidelines

Polyarteritis Nodosa Mimicking Peripheral Vascular Disease

Patients with Multiple Chronic Conditions Do Not Receive Lower Quality of Preventive Care

Two Deaths

Numeracy and Communication with Patients: They Are Counting on Us

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

Antikörper mobilisiert Neutrophile gegen Krebs

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

Update Innere Medizin